Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Daiichi Sankyo
Fish and Richardson
Cantor Fitzgerald

Generated: June 28, 2017

DrugPatentWatch Database Preview

DUTOPROL Drug Profile

« Back to Dashboard

What is the patent landscape for Dutoprol, and what generic Dutoprol alternatives are available?

Dutoprol is a drug marketed by Concordia Pharms Inc and is included in one NDA.

The generic ingredient in DUTOPROL is hydrochlorothiazide; metoprolol succinate. There are thirty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; metoprolol succinate profile page.

Summary for Tradename: DUTOPROL

Suppliers / Packagers: see list3
Bulk Api Vendors: see list67
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DUTOPROL at DailyMed

Pharmacology for Tradename: DUTOPROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Concordia Pharms Inc
hydrochlorothiazide; metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL021956-001Aug 28, 2006RXYesNo► Subscribe► Subscribe
Concordia Pharms Inc
hydrochlorothiazide; metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL021956-002Aug 28, 2006RXYesNo► Subscribe► Subscribe
Concordia Pharms Inc
hydrochlorothiazide; metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL021956-003Aug 28, 2006RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Federal Trade Commission
Argus Health
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus